The primary focus of our research is to uncover new vulnerabilities in the Ras-MAPK kinase pathway through the study of rare disease associated mutations within. We recently developed another BRET-based assay for measuring the auto inhibitory acti
Connectez-vous ou commencez votre essai gratuit pour accéder à ce contenu.